|
5-Iodo-indirubin-3'-monoxime
|
5-IODO-INDIRUBIN-3'-MONOXIME
|
331467-03-9
|
|
Abemaciclib methanesulfonate
|
LY2835219
|
1231930-82-7
|
|
Trilaciclib hydrochloride
|
曲拉西利雙鹽酸鹽
|
1977495-97-8
|
|
6-(Dimethylamino)purine
|
6-二甲基氨基嘌呤
|
938-55-6
|
|
(±)-Enitociclib
|
1610358-53-6
|
1610358-53-6
|
|
CDK5 inhibitor 20-223
|
CDK5 INHIBITOR 20-223
|
865317-30-2
|
|
hSMG-1 inhibitor 11e
|
化合物T35529
|
1402452-10-1
|
|
BSJ-4-116
|
化合物BSJ-4-116
|
2519823-34-6
|
|
KB-0742 dihydrochloride
|
KB-0742 dihydrochloride
|
2416874-75-2
|
|
CP681301
|
化合物 CP681301
|
865317-32-4
|
|
Senexin A
|
SENEXIN A
|
1366002-50-7
|
|
Ribociclib succinate hydrate
|
瑞柏司可里布(RIBOCICLIB LEE011)琥珀酸鹽水合物
|
1374639-79-8
|
|
hSMG-1 inhibitor 11j
|
嘧啶雜質(zhì)1
|
1402452-15-6
|
|
XL413 hydrochloride
|
XL413 HYDROCHLORIDE
|
2062200-97-7
|
|
SU9516
|
SU 9516
|
377090-84-1
|
|
Uliledlimab
|
尤萊利單抗
|
2378407-27-1
|
|
Mupadolimab
|
莫帕利單抗
|
2451856-97-4
|
|
YKL-5-124 TFA
|
|
2748220-93-9
|
|
BS-181 hydrochloride
|
BS181
|
1397219-81-6
|
|
CDK12-IN-3
|
CDK12-IN-3
|
2220184-50-7
|
|
CDK12-IN-E9
|
CDK12 inhibitor E9 S-isomer
|
2020052-55-3
|
|
CLK1-IN-1
|
2123491-32-5
|
2123491-32-5
|
|
DRAK2-IN-1
|
DRAK2-IN-1
|
871837-60-4
|
|
CD73-IN-3
|
5-[6-甲基-5-[(1S,2R)-2-丙-2-基環(huán)丙基]噠嗪-3-基]-1H-嘧啶-2,4-二酮
|
2375815-63-5
|
|
PROTAC CDK2/9 Degrader-1
|
|
2408641-24-5
|
|
CDK7/12-IN-1
|
化合物 CDK7/12-IN-1
|
2654075-94-0
|
|
(E/Z)-Zotiraciclib hydrochloride
|
化合物 (E/Z)-ZOTIRACICLIB HYDROCHLORIDE
|
1321626-25-8
|
|
NSC 107512
|
化合物 NSC 107512
|
22242-89-3
|
|
BMS-265246
|
BMS265246
|
582315-72-8
|
|
Longdaysin
|
9H-Purin-6-aMine, 9-(1-Methylethyl)-N-[[3-(trifluoroMethyl)phenyl]Methyl]-
|
1353867-91-0
|
|
Riviciclib hydrochloride
|
P276-00
|
920113-03-7
|
|
Voruciclib
|
VORUCICLIB
|
1000023-04-0
|
|
dCeMM2
|
化合物 DCEMM2
|
296771-07-8
|
|
Lerociclib dihydrochloride
|
LEROCICLIB HCL ; G1T38 DIHYDROCHLORIDE ; G1T 38 DIHYDROCHLORIDE
|
2097938-59-3
|
|
(-)-Enitociclib
|
(-)-BAY-1251152
|
1610358-59-2
|
|
CDK9-IN-8
|
CDK9-IN-8
|
2105956-51-0
|
|
NGR peptide
|
細胞穿膜肽 NGR PEPTIDE
|
651328-78-8
|
|
Atuveciclib S-Enantiomer
|
Atuveciclib S-Enantiomer
|
250279-81-1
|
|
CDK8-IN-1
|
CDK8-IN-1
|
1629633-48-2
|
|
Aminopurvalanol A
|
AMINOPURVALANOL A
|
220792-57-4
|
|
NVP 231
|
NVP-231
|
362003-83-6
|
|
MBQ-167
|
MBQ 167;MBQ167
|
2097938-73-1
|
|
Mevociclib
|
SY-1365
|
1816989-16-8
|
|
CKI-7 free base
|
CKI-7
|
120615-25-0
|
|
Cdc7-IN-1
|
CDC7-IN-1 (COMPOUND 13)
|
1402055-25-7
|
|
WEE1-IN-5
|
化合物DEBIO-0123
|
2243882-74-6
|
|
CDK4/6-IN-6
|
CDK4/6-IN-6
|
2380321-51-5
|
|
CPS2
|
化合物 CPS2
|
2756741-90-7
|
|
CVT-313
|
CVT 313
|
199986-75-9
|
|
AT7519 Hydrochloride
|
N-(4-哌啶基)-4-(2,6-二氯芐氨基)-1H-吡唑-3-羧胺鹽酸鹽
|
902135-91-5
|
|
PHA-793887
|
3-甲基-N-[1,4,5,6-四氫-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲?；鵠吡咯并[3,4-C]吡唑-3-基]丁酰胺
|
718630-59-2
|
|
AUZ 454
|
K03861
|
853299-07-7
|
|
THZ2
|
THZ2
|
1604810-84-5
|
|
Dalcetrapib
|
CETP抑制劑
|
211513-37-0
|
|
CDKI-73
|
CS-2259
|
1421693-22-2
|
|
MSC2530818
|
MSC2530818
|
1883423-59-3
|
|
Fadraciclib
|
CYC-065
|
1070790-89-4
|
|
CDK8-IN-4
|
CDK8-IN-4
|
1613638-82-6
|
|
TNIK-IN-3
|
化合物TNIK-IN-3
|
2754265-25-1
|
|
DB1113
|
|
2769753-53-7
|
|
Anacetrapib
|
安塞曲匹
|
875446-37-0
|
|
RGB-286638
|
N-[1,4-二氫-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-嗎啉基脲鹽酸鹽
|
784210-87-3
|
|
CK7
|
CDK2/9 INHIBITOR
|
507487-89-0
|
|
BRD6989
|
BRD6989
|
642008-81-9
|
|
THAL-SNS-032
|
THAL-SNS-032
|
2139287-33-3
|
|
CDK12-IN-2
|
化合物CDK12-IN-2
|
2244987-03-7
|
|
Abemaciclib
|
阿貝西利
|
1231929-97-7
|
|
CDK9-IN-2
|
N2'-(反式-4-氨基環(huán)己基)-5'-氯-N6-[(3-氟苯基)甲基]-[2,4'-聯(lián)吡啶]-2',6-二胺
|
1263369-28-3
|
|
Narazaciclib
|
8-環(huán)戊基-7,8-二氫-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈
|
1357470-29-1
|
|
Palbociclib-d8
|
帕博西尼-D8
|
1628752-83-9
|
|
Trilaciclib
|
曲拉西利
|
1374743-00-6
|
|
Indirubin-3′-oxime
|
(2Z,3E)-3-(羥基亞氨基)-[2,3'-聯(lián)吲哚啉亞基]-2'-酮
|
667463-82-3
|
|
PNU112455A hydrochloride
|
N4-(6-AMINOPYRIMIDIN-4-YL)-SULFANILAMIDE HCL
|
21886-12-4
|
|
AZD4573
|
AZD4573
|
2057509-72-3
|
|
NG 52
|
2-[[6-[(3-氯苯基)氨基]-9-異丙基-9H-嘌呤-2-基]氨基]乙醇
|
212779-48-1
|
|
FN-1501
|
1429515-59-2
|
1429515-59-2
|
|
CDK4/6-IN-2
|
CDK4/6-IN-2
|
1800506-48-2
|
|
Eciruciclib
|
化合物 ECIRUCICLIB
|
1868086-40-1
|
|
CD73-IN-4
|
化合物CD73-IN-4
|
2216764-29-1
|
|
NCT02
|
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺
|
790245-61-3
|
|
KH-CB20
|
|
1354448-60-4
|
|
AT7519
|
4-[(2,6-二氯芐基)氨基]-N-4-哌啶1H-吡唑-3-羧胺
|
844442-38-2
|
|
Bisindolylmaleimide X hydrochloride
|
BISINDOLYLMALEIMIDE X HYDROCHLORIDE (BIM-X HYDROCHLORIDE)
|
145317-11-9
|
|
Ribociclib hydrochloride
|
7-環(huán)戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺鹽酸鹽
|
1211443-80-9
|
|
THZ531
|
THZ531
|
1702809-17-3
|
|
SR-4835
|
SR-4835
|
2387704-62-1
|
|
CDK9-IN-7
|
CDK9-IN-7
|
2369981-71-3
|
|
SRI-29329
|
化合物SRI-29329
|
2086809-58-5
|
|
AZ5576
|
化合物AZ5576
|
2751721-40-9
|
|
Milciclib
|
PHA-848125
|
802539-81-7
|
|
Ribociclib succinate
|
LEE011 琥珀酸鹽
|
1374639-75-4
|
|
HS38
|
2-[[1-(3-Chlorophenyl)-4-oxo-5H-pyrazolo[5,4-d]pyrimidin-6-yl]sulfanyl]propanamide
|
1030203-81-6
|
|
NVP-2
|
化合物NVP-2
|
1263373-43-8
|
|
LY3177833
|
CS-2783
|
1627696-51-8
|
|
Enitociclib
|
1610358-56-9
|
1610358-56-9
|
|
CC-671
|
CC-671
|
1618658-88-0
|
|
HS-243
|
HS-243
|
848249-10-5
|
|
SY-5609
|
7-(二甲基膦基)-3-[2-[[(3S)-6,6-二甲基-3-哌啶基]氨基]-5-(三氟甲基)-4-嘧啶基]-1H-吲哚-6-甲腈
|
2417302-07-7
|
|
Rintodestrant
|
RINTODESTRANT
|
2088518-51-6
|
|
Ipivivint
|
IPIVIVINT
|
1481617-15-5
|